Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125608551 | 12560855 | 1 | I | 20160704 | 20160715 | 20160715 | EXP | US-ACTAVIS-2016-15272 | WATSON | RASHIDI A, OAK E, CARSON KR, WAGNER-JOHNSTON ND, KREISEL F, BARTLETT NL. OUTCOMES WITH R-CEOP FOR R-CHOP-INELIGIBLE PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA ARE HIGHLY DEPENDENT ON CELL OF ORIGIN DEFINED BY HANS CRITERIA. LEUK LYMPHOMA. 2016;57(5):1191-1193. | 85.00 | YR | M | Y | 0.00000 | 20160715 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125608551 | 12560855 | 1 | PS | Etoposide (Watson Laboratories) | ETOPOSIDE | 1 | Unknown | UNK, 3 CYCLES | UNCONFIRMED | 74968 | UNK | ||||||||
| 125608551 | 12560855 | 2 | SS | Vincristine (Unknown) | VINCRISTINE | 1 | Unknown | UNK, 3 CYCLES | UNCONFIRMED | 0 | UNK | ||||||||
| 125608551 | 12560855 | 3 | SS | Prednisone (Watson Laboratories) | PREDNISONE | 1 | Unknown | UNK | UNCONFIRMED | 0 | UNK | ||||||||
| 125608551 | 12560855 | 4 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | UNK,3 CYCLES | 0 | ||||||||||
| 125608551 | 12560855 | 5 | SS | RITUXIMAB | RITUXIMAB | 1 | Unknown | UNK, THREE CYCLES | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125608551 | 12560855 | 1 | Diffuse large B-cell lymphoma |
| 125608551 | 12560855 | 2 | Diffuse large B-cell lymphoma |
| 125608551 | 12560855 | 3 | Diffuse large B-cell lymphoma |
| 125608551 | 12560855 | 4 | Diffuse large B-cell lymphoma |
| 125608551 | 12560855 | 5 | Diffuse large B-cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125608551 | 12560855 | OT |
| 125608551 | 12560855 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125608551 | 12560855 | Infection | |
| 125608551 | 12560855 | Urosepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |